- Home
- INTC vs JNJ Comparison
INTC vs JNJ Comparison
Compare INTC & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTC | JNJ |
|---|---|---|
| Founded | 1968 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.6B | 505.3B |
| IPO Year | N/A | 1944 |
Fundamental Metrics
Financial Performance| Metric | INTC | JNJ |
|---|---|---|
| Price | $49.01 | $219.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 31 | 15 |
| Target Price | $35.34 | ★ $209.27 |
| AVG Volume (30 Days) | ★ 92.2M | 7.8M |
| Earning Date | 01-22-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | N/A | ★ 71.26 |
| EPS | 0.05 | ★ 10.35 |
| Revenue | $53,439,000,000.00 | ★ $92,149,000,000.00 |
| Revenue This Year | $0.95 | $6.63 |
| Revenue Next Year | $2.02 | $5.49 |
| P/E Ratio | $1,073.23 | ★ $21.22 |
| Revenue Growth | N/A | ★ 5.08 |
| 52 Week Low | $17.67 | $141.50 |
| 52 Week High | $50.39 | $219.75 |
Technical Indicators
Market Signals| Indicator | INTC | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 72.47 | 71.80 |
| Support Level | $38.95 | $203.85 |
| Resistance Level | $50.39 | $208.98 |
| Average True Range (ATR) | 2.25 | 3.39 |
| MACD | 1.05 | 1.24 |
| Stochastic Oscillator | 86.14 | 98.33 |
Price Performance
Historical ComparisonAbout INTC Intel Corporation
Intel is a leading digital chipmaker, focused on the design and manufacturing of microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors and led the semiconductor industry down the path of Moore's law for advances in semiconductor manufacturing. Intel remains the market share leader in central processing units in both the PC and server end markets. Intel is seeking to reinvigorate its chip manufacturing business, Intel Foundry, while developing leading-edge products within its Intel Products business segment.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.